[go: up one dir, main page]

WO2000000188A3 - Synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof - Google Patents

Synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof Download PDF

Info

Publication number
WO2000000188A3
WO2000000188A3 PCT/NO1998/000379 NO9800379W WO0000188A3 WO 2000000188 A3 WO2000000188 A3 WO 2000000188A3 NO 9800379 W NO9800379 W NO 9800379W WO 0000188 A3 WO0000188 A3 WO 0000188A3
Authority
WO
WIPO (PCT)
Prior art keywords
overweight
prophylaxis
treatment
citric acid
acid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NO1998/000379
Other languages
French (fr)
Other versions
WO2000000188A2 (en
Inventor
Erling Thom
Jarl Kjeldstadli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PEMBY Ltd
Original Assignee
PEMBY Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PEMBY Ltd filed Critical PEMBY Ltd
Priority to EP98967120A priority Critical patent/EP1007027A2/en
Priority to JP2000556773A priority patent/JP2002538075A/en
Priority to AU55368/99A priority patent/AU5536899A/en
Publication of WO2000000188A2 publication Critical patent/WO2000000188A2/en
Publication of WO2000000188A3 publication Critical patent/WO2000000188A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The claimed invention relates to a pharmaceutical synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof.
PCT/NO1998/000379 1998-06-18 1998-12-14 Synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof Ceased WO2000000188A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP98967120A EP1007027A2 (en) 1998-06-18 1998-12-14 Synthetically prepared composition for treatment and/or prophylaxis of overweight, and use thereof
JP2000556773A JP2002538075A (en) 1998-12-14 1998-12-14 Synthetic composition for the treatment and / or prevention of overweight and use thereof
AU55368/99A AU5536899A (en) 1998-06-18 1998-12-14 Synthetically prepared composition for treatment and/or prophylaxis of overweight, and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO982818A NO982818L (en) 1998-06-18 1998-06-18 Synthetically prepared preparation for the treatment and / or prophylaxis of obesity, and its use
NO19982818 1998-06-18

Publications (2)

Publication Number Publication Date
WO2000000188A2 WO2000000188A2 (en) 2000-01-06
WO2000000188A3 true WO2000000188A3 (en) 2000-03-16

Family

ID=19902163

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NO1998/000379 Ceased WO2000000188A2 (en) 1998-06-18 1998-12-14 Synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof

Country Status (5)

Country Link
EP (1) EP1007027A2 (en)
CN (1) CN1309559A (en)
AU (1) AU5536899A (en)
NO (1) NO982818L (en)
WO (1) WO2000000188A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4646409B2 (en) 1999-04-08 2011-03-09 ダウ グローバル テクノロジーズ インコーポレイティド Process for hydrooxidizing olefins to olefin oxides using oxidized gold catalysts
US20030004215A1 (en) * 2001-06-15 2003-01-02 Van Laere Katrien Maria Jozefa Dietetic preparation and method for inhibiting intestinal carbohydrate absorption
EP1410722A1 (en) * 2002-10-16 2004-04-21 Nutricia N.V. Weight loss kit and method for losing weight
DE102010053748B4 (en) * 2010-12-08 2023-08-03 Jörg Schierholz Pharmaceutical composition for the treatment of obesity

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993667A (en) * 1973-07-05 1976-11-23 Hoffmann-La Roche Inc. Hydroxycitric acid derivatives
US4005086A (en) * 1973-07-05 1977-01-25 Hoffmann-La Roche Inc. Hydroxycitric acid derivatives
WO1996005741A1 (en) * 1994-08-24 1996-02-29 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and method of making
WO1996036585A1 (en) * 1995-05-15 1996-11-21 Sabinsa Corporation A new process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993667A (en) * 1973-07-05 1976-11-23 Hoffmann-La Roche Inc. Hydroxycitric acid derivatives
US4005086A (en) * 1973-07-05 1977-01-25 Hoffmann-La Roche Inc. Hydroxycitric acid derivatives
WO1996005741A1 (en) * 1994-08-24 1996-02-29 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and method of making
WO1996036585A1 (en) * 1995-05-15 1996-11-21 Sabinsa Corporation A new process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE STN CAPLUS 1 January 1900 (1900-01-01), SINGH R P, JAYAPRAKASHA G K, SAKARIAH K K: "(-)-Hydroxycitric Acid from Garcinia Cambogia", XP002921043, Database accession no. 1996:43524 *

Also Published As

Publication number Publication date
AU5536899A (en) 2000-01-17
NO982818D0 (en) 1998-06-18
NO982818L (en) 2000-03-15
CN1309559A (en) 2001-08-22
WO2000000188A2 (en) 2000-01-06
EP1007027A2 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
WO2000004891A3 (en) Anti-ulcer composition
HUP0201409A2 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
WO2001045679A3 (en) Use of chemotherapeutic agents for topical treatment
HUP0102899A3 (en) Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
CA2392879A1 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
CA2289717A1 (en) Novel therapy for constipation
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
IL139658A0 (en) Pharmaceutical compositions for treatment and prophylaxis and method for their preparation
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
WO2000021510A3 (en) Formulations of fexofenadine
WO2000045800A3 (en) Immunosurpressive effects of pteridine derivatives
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
HUP9603607A3 (en) Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis
AU1367397A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
WO2001010408A3 (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
WO2003020963A3 (en) Proteins in type 2 diabetes
WO2000000188A3 (en) Synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
IL116826A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
IL116827A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis
HUP0204336A3 (en) Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use and pharmaceutical compositions containing them their

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 98808260.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998967120

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 1998967120

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998967120

Country of ref document: EP